BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2019
View Archived Issues
Neurotransmitter receptor stimulates early blood cell progenitors
Read More
Presentation of phase I results of PEN-866 in patients with advanced solid tumors
Read More
Knockdown of Fas death receptor shows hepatoprotective effect against NASH in mice
Read More
Novel PDE-delta inhibitor disrupts its interaction with mutant KRAS and inhibits tumor growth
Read More
BETonMACE phase III epigenetics study does not meet primary endpoint
Read More
Cabaletta Bio receives FDA IND clearance to initiate first-in-human study of DSG3-CAART
Read More
FDA clears IND for rapid personalized manufacture of CD19-specific CAR-T
Read More
TLC initiates phase III pivotal EXCELLENCE study of TLC-599
Read More
Preclinical and early clinical data for BBT-877 reported
Read More
Fluzoparib shows promising antitumor activity in advanced BRCA1/2-mutated ovarian cancer
Read More
Phase II data presented for ampreloxetine as treatment of neurogenic orthostatic hypotension
Read More
RELIEF study supports use of pirfenidone in non-IPF lung fibrosis
Read More
PharmaBlock Sciences patents PRMT5 inhibitors
Read More
Fujian Haixi Pharmaceuticals presents new CSF-1R inhibitors
Read More
Sunshine Lake Pharma identifies new PD-1/PD-L1 interaction inhibitors
Read More
Agenus patents anti-CD73 antibodies for cancer
Read More
Lundbeck discloses antibodies targeting tau
Read More
Phase II study of NCX-470 in open-angle glaucoma or ocular hypertension meets primary endpoint
Read More
Equillium initiates phase Ib study of itolizumab in lupus nephritis
Read More
Humanetics' development of radioprotectant BIO-301 supported by DoD cooperative research agreement
Read More
Checkmate's CMP-001 studied in combinations with Bavencio for SCCHN
Read More
IL-11 identified as therapeutic target in pulmonary fibrosis
Read More
New registrational study evaluates miransertib in Proteus syndrome and PROS
Read More
ContraFect plans single phase III study of exebacase for S. aureus bacteremia
Read More
